Head-to-head · WeighScore
AVArx vs Get Thin MD
The verdict
Get Thin MD takes it — 66.7/100 to 55.9/100.
Get Thin MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Get Thin MD is a nationwide async telehealth platform offering compounded semaglutide and tirzepatide injections plus brand-name Ozempic and Zepbound where appropriate, alongside a broader wellness menu…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AVArx | Get Thin MD |
|---|---|---|
| WeighScore | 55.9/100 | 66.7/100 |
| Grade | C | C |
| Scorecard rank | #426 | #179 |
| Semaglutide | Not disclosed | $199/mo (compounded) |
| Tirzepatide | Not disclosed | $299/mo (compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #426 · C
Strengths
- Publishes exactly which states require a live audio or video visit before a prescription, which almost no competitor discloses
- Names its prescribing group, Arora Health & Aesthetics, and gives a medical compliance contact
- Terms state service is available to residents of all 50 states, and the shipping policy matches
- Dates its own editorial reviews on treatment pages
- HSA/FSA accepted with receipts provided for reimbursement
Where it loses points
- No price is published anywhere on the site, on treatment pages or in the intake, so you cannot compare before starting a visit
- Never states whether its semaglutide and tirzepatide are compounded or brand-name
- No dispensing pharmacy is named, only licensed pharmacies in our network
- Cancellation terms are not published, only presented at checkout
- Prescriptions cannot be returned once dispensed, and the refund policy is otherwise unstated
Graded #179 · C
Strengths
- 3-month compounded semaglutide at $169/mo is among the lowest ongoing prices in the category
- Price-lock promise — same price every dose, no hidden fees
- Both compounded and brand-name options on one platform (sema, tirz, plus Ozempic and Zepbound)
- Nationwide availability with async evaluation — no in-person visit
- Broader wellness menu (sermorelin, NAD+, HRT, hair loss) lets you consolidate protocols
Where it loses points
- Compounded medications aren't FDA-approved and lack the review of brand-name GLP-1s
- Pharmacy partners not named — no way to verify the compounding source or batch testing
- Claims nationwide coverage but publishes no state list — confirm at intake
- Headline results (9.6 lbs in 30 days) come from self-reported patient data, not a trial
- Wide wellness funnel may steer you toward non-weight-loss protocols
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.